Harvard Apparatus Regenerative Technology Inc. (HRGN)
OTCMKTS · Delayed Price · Currency is USD
1.770
-0.030 (-1.67%)
At close: Mar 2, 2026

HRGN Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
314770672512
Market Cap Growth
-25.04%-31.84%3.94%170.54%110.90%-25.56%
Enterprise Value
304468682310
Last Close Price
1.772.984.995.502.301.25
PS Ratio
41.88110.32675.70---
PB Ratio
20.0214.7242.2867.70-8.1710.43
P/TBV Ratio
20.0214.7242.28--10.43
EV/Sales Ratio
40.41102.73662.13---
Debt / Equity Ratio
0.140.090.030.15-0.060.52
Net Debt / Equity Ratio
-0.70-0.68-0.23-1.130.43-0.39
Net Debt / EBITDA Ratio
0.170.300.040.190.150.09
Net Debt / FCF Ratio
0.260.450.060.220.490.11
Asset Turnover
0.190.120.04---
Inventory Turnover
9.224.15----
Quick Ratio
1.512.660.450.930.301.46
Current Ratio
1.863.170.811.170.332.22
Return on Equity (ROE)
-241.97%-317.67%-678.94%---439.48%
Return on Assets (ROA)
-104.72%-128.01%-224.12%-177.74%-273.85%-163.63%
Return on Capital Employed (ROCE)
-394.10%-211.20%-546.20%-585.00%290.80%-403.40%
Earnings Yield
-20.97%-16.30%-12.85%-9.07%-32.23%-41.45%
FCF Yield
--10.23%-9.99%-7.63%-10.62%-34.49%
Buyback Yield / Dilution
-13.38%-9.91%-18.56%-12.79%-14.43%-27.48%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.